Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville
Exciting News from Inotiv, Inc.
WEST LAFAYETTE, Ind., July 26, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV)
Attention all science enthusiasts and industry professionals, we have some exciting news to share! Inotiv, Inc., a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, has recently announced a significant expansion of its capacity to conduct Good Laboratory Practice (GLP) assays at its Rockville location. This expansion further solidifies Inotiv’s position as a key player in the field of genetic toxicology.
At Inotiv, we are dedicated to providing high-quality services and research models to support the development of safe and effective pharmaceutical products. Our team of experts is committed to excellence and innovation, and this latest expansion is a testament to our ongoing efforts to enhance our capabilities and meet the needs of our clients.
With the addition of GLP assays at our Rockville facility, we are now able to offer a comprehensive suite of genetic toxicology services to our clients. These assays are essential for evaluating the potential of drug candidates to cause genetic mutations, chromosomal damage, and other adverse effects. By expanding our genetic toxicology offering, we are better equipped to help our clients identify and mitigate potential risks early in the drug development process.
Our commitment to quality and compliance is reflected in our adherence to GLP standards, which ensure the reliability and integrity of our data. Clients can trust that our results are accurate, reproducible, and scientifically sound, giving them the confidence they need to make informed decisions about their drug development programs.
In addition to our genetic toxicology services, we also offer a wide range of other nonclinical and analytical services, as well as research models and related products. Whether you need support for safety assessment, metabolism studies, bioanalytical analysis, or something else, Inotiv has you covered.
Join us in celebrating this exciting milestone for Inotiv, Inc. as we continue to expand our genetic toxicology offering and enhance our capabilities to support the development of safe and effective pharmaceutical products. We look forward to partnering with you on your next drug development project!
How this News Will Affect Me
As a scientist or industry professional, this news is significant as it signifies Inotiv’s dedication to providing high-quality services in the field of genetic toxicology. By expanding their capacity to conduct GLP assays at the Rockville facility, Inotiv is better equipped to help clients like me evaluate the safety of drug candidates and identify potential risks early in the drug development process. This can ultimately lead to the development of safer and more effective pharmaceutical products, benefiting both me and the patients who rely on these medications.
How this News Will Affect the World
The expansion of Inotiv’s genetic toxicology offering with the support of GLP assays at the Rockville facility has the potential to have a positive impact on the world at large. By providing comprehensive genetic toxicology services to pharmaceutical companies and researchers, Inotiv is contributing to the development of safer medications that can improve the health and well-being of people around the globe. This news highlights the importance of rigorous safety assessment in drug development and demonstrates Inotiv’s commitment to excellence and innovation in the field.
Conclusion
Inotiv, Inc.’s continued expansion of its genetic toxicology offering with the support of GLP assays at the Rockville facility is a significant milestone for the company and the industry as a whole. This news underscores Inotiv’s commitment to quality, compliance, and innovation, and reinforces their position as a leading contract research organization in the field of nonclinical and analytical drug discovery and development services. As we look to the future, we can expect Inotiv to play a key role in advancing the development of safe and effective pharmaceutical products that benefit both individuals and society as a whole.
